1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legislation

Senate Panel Supports $56 Million Boost For NIH Translational Science Center

The National Center for Advancing Translational Sciences would get a sizable chunk of the funding increase approved for NIH by the Senate Appropriations Committee but support for increasing its budget is not universal.

The Senate Appropriations Committee voted June 14 to boost the National Center for Advancing Translational Sciences budget by $56.5 million, or 9.8%, in fiscal 2013, a sizable chunk of the $100 million increase the committee approved for the entire National Institutes of Health, where NCATS is housed.

NCATS, formally established in January, is an effort by NIH Director Francis Collins to facilitate the transition of scientific discoveries...

Welcome to Medtech Insight

Create an account to read this article

Already a subscriber?

More from Legislation

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 
• By Natasha Barrow

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

Planning To Take Part in MDUFA? FDA Wants To Hear From You

 
• By Brian Bossetta

The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.

Final Curtain For LDTs? FDA Will Not Appeal District Court Decision To Vacate Final Rule

 
• By Brian Bossetta

The US FDA has given up on its effort to regulate lab-developed tests as medical devices, at least for now. The agency will not appeal a decision from the Eastern District of Texas that tossed out the FDA’s final rule, leaving the agency with few cards.

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

More from Policy & Regulation